CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer

Documenti analoghi

• TSPAN31 Activates Fatty Acid Metabolism and PI3K/AKT Pathway to Promote Tumor Progression in Breast Cancer
  di: Wenquan Luo, et al.
  Pubblicazione: (2025)
• RETRACTION: LINC02381 Aggravates Breast Cancer Through the miR‐1271‐5p/FN1 Axis to Activate PI3K/AKT Pathway
  Pubblicazione: (2024)
• Withaferin A Exerts Cytotoxicity in Single/Multidrug‐Resistant Gastric and Ovarian Cancer Cells and Tumor Xenografts Through the AKT–NF‐κB–STAT3–Survivin Axis
  di: Priti S. Shenoy, et al.
  Pubblicazione: (2025)
• Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway
  di: Shangwei Xu, et al.
  Pubblicazione: (2025)
• ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer
  di: Dongsheng He, et al.
  Pubblicazione: (2024)